Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-25 @ 3:52 AM
Ignite Modification Date: 2025-12-25 @ 3:52 AM
NCT ID: NCT06557902
Eligibility Criteria: Inclusion Criteria: * Male or female patients between 5 to less than 13 years of age * Primary clinical diagnosis of ASD with symptoms of irritability * ABC-I subscale score of ≥12 at Screening * CGI-S score of ≥3 at Screening * Body mass index (BMI) greater than the 5th percentile according to age- and gender-specific CDC Clinical Growth Charts (2000) at Screening * Ability to swallow capsules Exclusion Criteria: * Has a primary psychiatric diagnosis other than ASD * Reports suicidal ideation (Type 3, 4 or 5 on the Baseline/Screening version of the C-SSRS) within 6 months prior to Screening, or any suicidal behavior within 2 years prior to Screening, and/or the Investigator assesses the patient to be a safety risk to him/herself or others * Clinically significant abnormality within 2 years of Screening that in the Investigator's opinion may place the patient at risk or interfere with study outcome variables * History of a clinically significant cardiac disorder and/or abnormal screening ECG or a QT interval corrected for heart rate using Fridericia formula (QTcF) \> 460 msec at Screening * Patients with a history of orthostatic hypotension or who have orthostatic hypotension at Screening * Has a history of uncontrolled/disruptive behavior in the past 30 days that, in the Investigator's opinion, would preclude the ability to participate in study procedures
Healthy Volunteers: False
Sex: ALL
Minimum Age: 5 Years
Maximum Age: 12 Years
Study: NCT06557902
Study Brief:
Protocol Section: NCT06557902